This article is a collaboration between 鶹ý and:
PHILADELPHIA -- How much urgency is there to a positive stress test for stable angina patients? Why might a coronary angiography-first strategy be on the table? And how key is medical optimization when a patient is headed to the cath lab?
The landmark ISCHEMIA trial that showed early revascularization wasn't better than optimal medical therapy alone for stable ischemic heart disease patients also held the answers to these questions, as our panelists explore in this exclusive video.
Watch the discussion here at the with:
- Robert Harrington, MD, AHA president
- Jennifer Robinson, MD, MPH, vice-chair of the 2013 AHA/American College of Cardiology cholesterol guidelines
- Jay Giri, MD, MPH, director of the Cardiovascular Catheterization Laboratory at the VA Medical Center in Philadelphia